Global Human Microbiome Market Size, Trends & Growth Opportunity by Product (Prebiotic, Probiotic, Food, Medical Food, Drug), Application (Therapeutic), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, Neurological), Research Technology (Proteomics, Metabolomics), Region and Forecast till 2027.

Global Human Microbiome Market

The Global Human Microbiome Market is estimated to be USD 599 Mn in 2021 and is projected to reach USD 3,127.91 Mn by 2027, growing at a CAGR of 21.75 %. Human microbiota is known as human tissues are covered with millions of microorganisms such as viruses, bacteria, and fungi. The microbiome is made up of all the genes found within these organisms.Human microbiomes play an important role in advanced healthcare, as they enable easy digestion of food and the production of vitamins such as vitamin K, B, and B12, which are important for blood coagulation.
Market Drivers
The increase in incidence of lifestyle diseases and the rise in focus on human microbiome therapies are expected to boost the global human microbiome market's growth over the forecast period. Further, the rise in technological advancements in meta-genomics and next-generation sequencing will positively influence the global human microbiome market. Also, the rise in the ageing population will drive the market growth. In addition to that, the rise in partnership, collaboration, and mergers and acquisition activities by key operating players will propel the global human microbiome market growth over the forecast period.
Market Restraints
Lack of qualified personnel and detailed research is the major restraint that is expected to hinder the global human microbiome market. Also, stringent government regulations will limit the global human microbiome market's growth during this forecast timeline.
Market Segmentation
The Global Human Microbiome Market is segmented by Product such as prebiotics, probiotics, food, medical food, and drugs. Further market is segmented into application (therapeutic), disease (infectious, metabolic/endocrine, cancer, blood, and neurological), and research technology (proteomics and metabolics).Also, the Global  Human Microbiome Market is segmented into five regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa.

Market key Players
Various key players are discussed in the global human microbiome market report including Enterome, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Synthetic Biologics, Inc, DuPont, BiomX Ltd, MaaT Pharma, and Eligo Bioscience.
Industry development
September 2022: Seres Therapeutics Inc completed the submission process for its BLA application to the FDA for SER-109 to prevent recurrent C. difficile infection (rCDI). It is an entirely new treatment modality that promises to improve the current standard of care for rCDI.

September 2022: Ferring Pharmaceuticals received a positive vote for RBX2660 by the Vaccines and Related Biological Products Advisory Committee of the FDA for its investigational microbiota-based live biotherapeutic study for its potential to reduce the recurrence of C. difficile infection (CDI) after antibiotic treatment.

Market Taxonomy
By Product
• Prebiotic
• Probiotic
• Food
• Medical Food
• Drug

By Application
• Therapeutic
• Disease
1.        Infectious
2.        Metabolic/Endocrine
3.        Cancer
4.        Blood
5.        Neurological
6.        Research Technology 
7.        Proteomics
8.        Metabolomics
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Key Questions Addressed by the Report
• What are the Key Opportunities in Global Human Microbiome Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?
 

Global Human Microbiome Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Human Microbiome Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Human Microbiome Market, By Product
5.1 Y-o-Y Growth Comparison, By Product 
5.2 Global Human Microbiome Market Share Analysis, By Product 
5.3 Global Human Microbiome Market Size and Forecast, By Product
5.3.1 Prebiotic
5.3.2 Probiotic
5.3.3 Food
5.3.4 Medical Food
5.3.5 Drug 
6 Global Human Microbiome Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Human Microbiome Market Share Analysis, By Application
6.3 Global Human Microbiome Market Size and Forecast, By Application
6.3.1 Therapeutic
6.3.2 Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, Neurological)
6.3.3 Research Technology (Proteomics, Metabolomics)
7 Global Human Microbiome Market, By Region
7.1 Global Human Microbiome Market Share Analysis, By Region
7.2 Global Human Microbiome Market Share Analysis, By Region
7.3 Global Human Microbiome Market Size and Forecast, By Region
8 North America Human Microbiome Market Analysis and Forecast (2022 – 2027)
8.1 Introduction
8.2 North America Human Microbiome Market Share Analysis, By Product
8.3 North America Human Microbiome Market Size and Forecast, By Application
8.4 North America Human Microbiome Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9 Europe Human Microbiome Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe Human Microbiome Market Share Analysis, By Product 
9.3 Europe Human Microbiome Market Size and Forecast, By Application 
9.4 Europe Human Microbiome Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10 Asia Pacific Human Microbiome Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Asia Pacific Human Microbiome Market Share Analysis, By Product 
10.3 Asia Pacific Human Microbiome Market Size and Forecast, By Application 
10.4 Asia Pacific Human Microbiome Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11 Latin America Human Microbiome Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America Human Microbiome Market Share Analysis, By Product 
11.3 Latin America Human Microbiome Market Size and Forecast, By Application 
11.4 Latin America Human Microbiome Market Size and Forecast, By Country
11.4.1 Brazil
11.4.2 Rest of Latin America
12 Middle East Human Microbiome Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East Human Microbiome Market Share Analysis, By Product 
12.3 Middle East Human Microbiome Market Size and Forecast, By Application 
12.4 Middle East Human Microbiome Market Size and Forecast, By Country
12.4.1. Saudi Arabia
12.4.2. UAE
12.4.3. Egypt
12.4.4. Kuwait
12.4.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Enterome
 14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Rebiotix Inc.
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Yakult Honsha Co., Ltd.
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Osel Inc.
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Vedanta Biosciences, Inc.
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Synthetic Biologics, Inc.
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 DuPont
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 BiomX Ltd
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 MaaT Pharma
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 Eligo Bioscience
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies